Stereotactic Body Radiotherapy in Bulky Hepatocellular Carcinoma with or without Portal Vein Thrombosis: A Feasibility Review in an Egyptian Cohort

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 58

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_MISJ-15-3_009

تاریخ نمایه سازی: 11 تیر 1403

چکیده مقاله:

Background: Hepatocellular carcinoma (HCC) complicated by portal vein thrombosis presents significant clinical challenges. This study aims to retrospectively assess the feasibility of stereotactic irradiation for treating bulky HCC, with or without vascular invasion.Method: In this retrospective analysis, the radiotherapy treatment plans and clinical follow-up data of ۲۲ patients diagnosed with HCC, with or without portal vein thrombosis, were reviewed. These patients underwent stereotactic body radiation therapy (SBRT) between September ۲۰۱۹ and September ۲۰۲۲. Treatment involved administering ۴۰-۵۰ Gy in ۵ fractions using SBRT with volumetric modulated arc therapy (VMAT)/۴D-computed tomography. Descriptive statistics were utilized without the application of statistical tests.Results: The mean age of the patients was ۶۵ years, with ۷۷% being male. Portal vein thrombosis was present in ۷۳% of the cases, and the average tumor size was ۷.۲ cm (range ۵-۱۲ cm). ۵۹% of patients were classified as Child-Pugh B. The median follow-up duration was ۸ months (range ۳-۳۶ months). At ۳ months, tumor response assessments revealed that ۵۹% of patients had a partial response and ۴۱% had stable disease; by ۶ months, ۳۷% achieved complete response, ۲۶% maintained a partial response, and ۳۷% had stable condition. Failure patterns included intrahepatic failure in two patients (at ۷ and ۹ months) and extrahepatic loss in two others (at ۶ and ۱۰ months). Radiation-induced liver disease occurred in two patients at ۹- and ۱۱-weeks post-treatment, respectively. Liver cancer-specific mortality was ۱۳.۶%, while non-liver cancer-specific mortality stood at ۹%. The progression-free survival rate was ۸۲%.Conclusion: SBRT via VMAT represents a highly cost-effective, non-invasive local therapy with a favorable therapeutic ratio for treating bulky HCC cases, with or without vascular invasion.

کلیدواژه ها:

نویسندگان

Mohamed Hegazy

Department of Clinical Oncology and Nuclear Medicine, Medicine College, Zagazig, Egypt

Hany Attallah

Department of Radiation Oncology, International Medical Center (IMC), Cairo, Egypt

Khaled El-Shahat

Department of Clinical Oncology, Al-Azhar College of Medicine, Cairo, Egypt

Emad Mostafa

Medical Radiation Physics, International Medical Center, Cairo, Egypt

Adel Yassin

Department of Clinical Oncology, Al-Azhar College of Medicine, Cairo, Egypt

Ibraheem Haggag

Medical Radiation Physics, International Medical Center, Cairo, Egypt

Talaat Fathy

Tropica Department, College of Medicine, Zagazig, Egypt

Sameh Abdel Monem

Tropica Department, College of Medicine, Zagazig, Egypt

Ahmed Abdelmoaty

Tropica Department, College of Medicine, Zagazig, Egypt

Ahmed Bessar

Radiology Department, College of Medicine, Zagazig, Egypt

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, ...
  • Apisarnthanarax S, Barry A, Cao M, Czito B, DeMatteo R, ...
  • Hong TS, Wo JY, Yeap BY, Ben-Josef E, McDonnell EI, ...
  • Ohri N, Tomé WA, Méndez Romero A, Miften M, Ten ...
  • Yoon SM, Ryoo BY, Lee SJ, Kim JH, Shin JH, ...
  • Bujold A, Massey CA, Kim JJ, Brierley J, Cho C, ...
  • Tanguturi SK, Wo JY, Zhu AX, Dawson LA, Hong TS. ...
  • Velec M, Haddad CR, Craig T, Wang L, Lindsay P, ...
  • Parzen JS, Hartsell W, Chang J, Apisarnthanarax S, Molitoris J, ...
  • Culleton S, Jiang H, Haddad CR, Kim J, Brierley J, ...
  • Que J, Kuo HT, Lin LC, Lin KL, Lin CH, ...
  • Lo CH, Huang WY, Lee MS, Lin KT, Lin TP, ...
  • Lasley FD, Mannina EM, Johnson CS, Perkins SM, Althouse S, ...
  • Gkika E, Schultheiss M, Bettinger D, Maruschke L, Neeff HP, ...
  • Chopra S, George K, Engineer R, Rajamanickam K, Nojin S, ...
  • Seo YS, Kim MS, Yoo SY, Cho CK, Choi CW, ...
  • Beaton L, Dunne EM, Yeung R, Rackley T, Weber B, ...
  • نمایش کامل مراجع